Error: Could not add to watchlist. X

Galectin Therapeutics Inc

+ Watchlist
GALT:US
NASDAQ CM
2.59
USD
0.03
1.17%
As of 20:10:00 ET on 07/08/2015.
Open
2.56
Day Range
2.55 - 2.65
Volume
102,322
Previous Close
2.56
52Wk Range
2.50 - 16.55
1 Yr Return
-79.94%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.73
Market Cap (m USD)
61.460
Shares Outstanding (m)
23.730
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Galectin Therapeutics Inc. is a drug development company. The Company creates new therapies for fibrotic disease and cancer using its carbohydrate technology that targets galectin proteins which are key mediators of biologic and pathologic functions. Gelectin uses naturally occurring carbohydrate polymers with galactose residues to create complex carbohydrates.
ADDRESS
4960 Peachtree Industrial Blvd
Norcross, GA 30071
United States
PHONE
1-678-620-3186
  • James C Czirr
    Chairman/Co-Founder
  • Peter G Traber
    President/CEO/Chief Medical Ofcr
  • Jack W Callicutt
    Chief Financial Officer
  • Harold H Shlevin
    Chief Operating Officer
  • Eliezer Zomer
    Exec VP:Manufacturing
Show More